Showing results (2161-2170 of 2,286) with videos related to

Sort By:
Pageof 229
Nature|February 5, 2010
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growthGeorgia Hatzivassiliou, Kyung Song, Ivana Yen, et al.
Journal of Affective Disorders|July 30, 2017
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorderOle Köhler-Forsberg, Trine Madsen, Ida Behrendt-Møller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial resultsD D Bigner, M T Brown, A H Friedman, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
Leukemia & Lymphoma|February 21, 2024
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOPRonald Nemec, Marielle Scherrer-Crosbie, Jeremy S Abramson, et al.
Psychiatric Services (Washington, D.C.)|July 1, 2009
Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patientsDavid J Kupfer, David A Axelson, Boris Birmaher, et al.
Frontiers in Veterinary Science|April 9, 2021
Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in DogsJason Chibuk, Andi Flory, Kristina M Kruglyak, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Carbohydrate consumption drives adaptive mutations in Escherichia coli associated with increased risk for systemic infectionAaron L Hecht, Nadim Mahmud, Subhan Chaudhry, et al.
Genomics|October 15, 1996
Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1K J Abel, L C Brody, J M Valdes, et al.
Journal of Affective Disorders|December 24, 2021
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment responseMaya Kuperberg, Ole Köhler-Forsberg, Alec P Shannon, et al.
Pageof 229